Can you fast while on treatment?
Quick answer
Fasting while taking a GLP-1 medicine may worsen nausea, dehydration or inadequate food intake, and can be riskier for people using insulin or certain diabetes medicines. Ask your clinician before fasting, especially if you have diabetes, other health conditions or troublesome side effects; do not change medication doses on your own.
Fasting may be possible for some people taking a GLP-1 medicine, but it is not necessary for treatment and is not safe for everyone. Reduced appetite can make it harder to eat and drink enough. Diabetes medicines, frailty, illness and the type of fast all change the risks.
What does fasting mean in this situation?
Intermittent fasting means restricting when you eat or having periods of very limited food intake. Religious fasting may also restrict fluids. These patterns have different safety implications. Glucagon-like peptide-1 (GLP-1) medicines, and the related medicine tirzepatide, can already reduce hunger and cause digestive symptoms. Adding a restrictive eating pattern is not automatically helpful.
Evidence does not establish a single fasting schedule that is safe or adds benefit for everyone using these medicines. You do not need to fast to show that you are committed to your health.
Why do your diabetes medicines matter?
Insulin and sulfonylureas, such as gliclazide, can cause hypoglycaemia, meaning low blood glucose. Missing meals can increase that risk. GLP-1 treatment alone is less likely to cause low glucose, but that does not make fasting safe when other medicines are involved. Arrange a medication review and an individual glucose-monitoring and fast-breaking plan before fasting. Never stop insulin or change doses without advice.
Sodium-glucose co-transporter-2 (SGLT2) inhibitors, such as dapagliflozin and empagliflozin, need particular attention. Restricted intake, dehydration and illness can contribute to diabetic ketoacidosis, a dangerous build-up of acids called ketones. This can occur even when glucose is not very high. Ask the diabetes team about fasting and sick-day rules rather than improvising a medicine break.
Who should avoid starting a fast without specialist advice?
Seek individual advice if you have diabetes, kidney disease, frailty, a history of an eating disorder, repeated dizziness or difficulty meeting nutritional needs. Frailty means reduced physical reserve and vulnerability to illness; it is not determined by age alone. Pregnancy, breastfeeding and growing children are not situations for self-directed weight-loss fasting.
Starting treatment or increasing the dose may bring nausea or vomiting. Wait for clinical advice rather than adding a fast while your intake is unsettled. During illness or dehydration, do not continue a fast simply to complete a schedule.
How can you protect nutrition and muscle?
A shorter eating window may leave too little opportunity to eat enough protein, energy, vitamins and minerals. Smaller regular meals may be more manageable than one large meal, particularly if your medicine makes you feel full quickly. Include protein foods and a varied diet, and discuss suitable strengthening activity. A dietitian can help if appetite is persistently low or you are becoming weaker.
For religious fasting, arrange a review in advance. Discuss hydration outside fasting hours, medicine timing, monitoring and whether an exemption is medically advisable. Taking an oral semaglutide tablet has its own fasting instructions; that is not a recommendation to extend fasting for weight loss.
When should you break the fast and get help?
Stop fasting if you develop symptoms of low glucose, such as shaking, sweating or confusion. Check your glucose if possible and follow your prescribed hypo treatment plan promptly. If someone is unconscious or cannot swallow safely, call 999 and do not give food or drink by mouth.
Seek urgent help for repeated vomiting, inability to keep fluids down, fainting or markedly reduced urine. Abdominal pain, deep or rapid breathing, unusual drowsiness or vomiting while taking an SGLT2 inhibitor require urgent assessment for ketoacidosis, even with a reassuring glucose reading. Severe persistent abdominal pain spreading to the back can also signal pancreatitis: stop the GLP-1 medicine and seek urgent medical care.
Sources & further reading
Reviewed by
Dr Chinnadorai Rajeswaran
Specialist Endocrinologist · MBBS MRCP FRCP
Last Reviewed: November 2026
Read about complex severe obesity and related care.
Related insights
Weight Regain After GLP-1 Treatment: Why It Happens
Weight regain after stopping GLP-1 treatment is common because appetite and weight-regulating biology persist, though individual responses differ. Discuss a long-term plan with the prescriber before stopping or restarting, and do not alter doses independently.
Foundayo (Orforglipron): What a Daily Tablet Changes
Foundayo is a once-daily orforglipron tablet licensed in the UK, offering an oral route without the fasting routine required for oral semaglutide. Taking a tablet rather than an injection does not remove the need for a doctor to assess suitability, monitor side effects and review ongoing treatment.
Oral or Injectable GLP-1: How We Choose a Route
Oral and injectable GLP-1 medicines differ in absorption, dosing, evidence, and practical considerations; neither route is automatically best for everyone. A prescriber should choose based on the specific product, medical history, preferences, and local approval, with instructions followed exactly.